US free shipping over $150 · Exact worldwide rate at checkout · Crypto-only checkout guide — Shop now
T
Titan PeptideResearch-grade nasal sprays

MOTS-c vs NAD+ · research class comparison

MOTS-c vs NAD+: a peptide and a coenzyme, not two versions of the same thing.

MOTS-c and NAD+ get grouped together because both show up in cellular-energy and mitochondrial research, and the search results blur them into a single 'longevity compound' bucket. Chemically they could not be further apart. MOTS-c is a 16-amino-acid mitochondrial-derived peptide — a short protein sequence encoded within the mitochondrial 12S rRNA region. NAD+ (nicotinamide adenine dinucleotide) is not a peptide at all; it is a dinucleotide coenzyme built from two nucleotides joined by phosphate groups. That single fact — peptide versus coenzyme — changes what each one is, how it is made and stored, and, most importantly for a buyer, how a credible release sheet has to verify it. This page lays out the class split in plain research terms. It makes no metabolic, longevity, anti-aging, energy, or human-use claim about either compound, and neither MOTS-c nor NAD+ is a core Titan catalog SKU — the honest routing is covered below.

MOTS-c is a peptide

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-residue mitochondrial-derived peptide — a genuine short amino-acid sequence. In laboratory research it is studied as a signalling peptide of mitochondrial origin, and it behaves like other research peptides in every practical way that matters here: it is synthesised as a defined sequence, supplied as a lyophilized powder, and its identity is a question of the correct sequence and mass. If you already understand how a peptide release sheet works, you already understand how MOTS-c should be verified.

Where to buy MOTS-c

NAD+ is a coenzyme, not a peptide

NAD+ is nicotinamide adenine dinucleotide — a small-molecule coenzyme made of two nucleotides (a nicotinamide unit and an adenine unit) linked through phosphate. There is no amino-acid chain, no peptide bond, and no sequence to confirm. It sits in a different chemistry family entirely, alongside its precursors NMN and NR. Treating it as 'a peptide like MOTS-c' is the exact error this page corrects: a peptide-style sequence-by-mass check does not even apply to a dinucleotide.

Where to buy NAD+

Why they get searched together

Both appear in the same corner of the literature — mitochondrial biology and cellular energy metabolism — so search engines and forums bundle them under 'longevity research compounds.' That shared topic is real, but a shared research area is not a shared molecule. One is a peptide, one is a coenzyme; they are prepared, stored, and tested differently. Understanding that they belong to two chemistry classes is the whole point of comparing them, and it is a mechanistic comparison only — no outcome, benefit, or efficacy is claimed for either.

Peptides vs SARMs (another class split)

The release sheet is verified differently

This is where the difference stops being academic. For MOTS-c — a peptide — a credible certificate confirms the correct 16-residue sequence by mass spectrometry and resolves purity by HPLC, with the certificate lot number matching the code on the unit you receive. For NAD+ — a coenzyme — there is no sequence to confirm by peptide mass; verification centers on compound identity and HPLC purity for the dinucleotide, and on distinguishing NAD+ from its precursors (NMN, NR), which are different molecules. A vendor that prints one generic 'tested' badge for both is telling you it does not understand what it is selling.

How to read a peptide COA

Storage and stability differ by class

As a lyophilized peptide, MOTS-c follows the same handling logic as other research peptides — kept dry and cold as a powder, with a defined window once reconstituted in bacteriostatic water. NAD+ and its nucleotide precursors have their own stability profile as small molecules and are not reconstituted the way a peptide vial is. Applying peptide storage rules blindly to a coenzyme, or vice-versa, is another reason the two should not be treated as interchangeable in a research setting.

Bacteriostatic water & reconstitution

What Titan actually stocks

Titan's RUO catalog is a focused set of in-house-tested research peptides — BPC-157, TB-500, retatrutide, the CJC-1295 + Ipamorelin blend, and a line of pre-mixed nasal-format peptides — rather than every compound the internet groups under 'longevity.' MOTS-c and NAD+ are not core catalog SKUs, so instead of implying a product it does not verify, Titan points researchers to the compounds it does test and to the verification standard that separates a real release sheet from a badge. The where-to-buy pages above cover the honest sourcing context for each.

Best research peptides (in stock)

The detail, in plain terms

The split, in plain terms.

MOTS-c and NAD+ overlap in research topic, not in chemistry. One is a peptide with a sequence; one is a coenzyme without one. That difference decides how each is made, stored, and — the part a buyer should care about — verified.

MOTS-c — what it is
16-residue mitochondrial-derived peptide (a short amino-acid sequence).
NAD+ — what it is
Nicotinamide adenine dinucleotide — a coenzyme, not a peptide. Precursors: NMN, NR.
Same molecule class?
No — peptide vs dinucleotide coenzyme. Different chemistry families.
MOTS-c identity check
Correct 16-mer sequence by mass spectrometry + HPLC purity, lot-matched.
NAD+ identity check
Compound identity + HPLC purity for the dinucleotide; distinguish from NMN/NR.
Titan stocks
Neither is a core SKU — honest redirect to in-catalog tested peptides.

Questions researchers ask

Before you order.

Is MOTS-c a peptide and is NAD+ a peptide?
MOTS-c is a peptide — a 16-amino-acid mitochondrial-derived sequence. NAD+ is not a peptide; it is a dinucleotide coenzyme (nicotinamide adenine dinucleotide) with no amino-acid chain and no peptide bond. They get searched together because both appear in mitochondrial and cellular-energy research, but they belong to two different chemistry classes. This is research framing only, not a human-use comparison.
Why do people compare MOTS-c and NAD+?
Because both show up in the same research area — mitochondrial biology and energy metabolism — so they get bundled under 'longevity compounds' in search and forums. A shared research topic is not a shared molecule, though: one is a peptide and one is a coenzyme, prepared and verified differently. Comparing them is about understanding the class split, not deciding which is 'better,' and no efficacy or outcome is claimed for either.
Should a MOTS-c COA and a NAD+ COA look the same?
No, and that is the practical takeaway. A MOTS-c release sheet should confirm the correct 16-residue sequence by mass spectrometry with HPLC purity, lot-matched to the unit. A NAD+ certificate cannot confirm a peptide sequence because there isn't one — it verifies compound identity and HPLC purity for the dinucleotide and should distinguish NAD+ from precursors like NMN and NR. A single generic 'tested' badge covering both is a red flag.
Does Titan sell MOTS-c or NAD+?
Neither is a core Titan catalog product. Titan's RUO line centers on in-house-tested research peptides such as BPC-157, TB-500, retatrutide, the CJC-1295 + Ipamorelin blend, and pre-mixed nasal-format peptides. Rather than list compounds it does not verify in-house, Titan points researchers to what it does stock and to the COA standard that applies to any research compound. The where-to-buy pages cover the honest sourcing context.
Are MOTS-c or NAD+ for human use?
No. Anything discussed here is strictly for in-vitro laboratory research. Neither MOTS-c nor NAD+ is for human or animal consumption, diagnostic, therapeutic, or preventative use, and no metabolic, longevity, energy, or anti-aging outcome is claimed for either. Nothing on this page is a dosing schedule or a human-use protocol — it is a chemistry and verification comparison only.